- Home
- RDN vs CRNX Comparison
RDN vs CRNX Comparison
Compare RDN & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RDN | CRNX |
|---|---|---|
| Founded | 1977 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5B | 4.5B |
| IPO Year | 2008 | 2018 |
Fundamental Metrics
Financial Performance| Metric | RDN | CRNX |
|---|---|---|
| Price | $34.42 | $39.02 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 9 |
| Target Price | $40.20 | ★ $74.78 |
| AVG Volume (30 Days) | ★ 1.2M | 933.3K |
| Earning Date | 05-20-2026 | 06-01-2026 |
| Dividend Yield | ★ 2.94% | N/A |
| EPS Growth | ★ 5.61 | N/A |
| EPS | ★ 4.14 | N/A |
| Revenue | ★ $1,197,084,000.00 | $1,039,000.00 |
| Revenue This Year | N/A | $730.30 |
| Revenue Next Year | $3.88 | $179.48 |
| P/E Ratio | $8.38 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $29.32 | $24.10 |
| 52 Week High | $38.84 | $57.99 |
Technical Indicators
Market Signals| Indicator | RDN | CRNX |
|---|---|---|
| Relative Strength Index (RSI) | 53.23 | 27.94 |
| Support Level | $34.20 | $33.23 |
| Resistance Level | $34.55 | $45.32 |
| Average True Range (ATR) | 0.94 | 1.93 |
| MACD | 0.14 | -0.36 |
| Stochastic Oscillator | 68.36 | 10.09 |
Price Performance
Historical ComparisonAbout RDN Radian Group Inc.
Radian Group Inc is engaged in mortgage and real estate services. It provides both credit-related mortgage insurance coverage and other products and services across the residential real estate and mortgage finance industries. It has one business segment Mortgage Insurance. The Mortgage Insurance segment aggregates, manages, and distributes U.S. mortgage credit risk for the benefit of mortgage lending institutions and mortgage credit investors, through private mortgage insurance on residential first-lien mortgage loans, and also offers other credit risk management solutions, including contract underwriting, to customers. It also provides other mortgage and real estate products and services through Mortgage Conduit, Title, Real Estate Services, and Real Estate Technology businesses.
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.